Found: 1
Select item for more details and to access through your institution.
Excision repair cross complementation group 1 is a chemotherapy-tolerating gene in cisplatin-based treatment for non-small cell lung cancer.
- Published in:
- International Journal of Oncology, 2015, v. 46, n. 2, p. 809, doi. 10.3892/ijo.2014.2784
- By:
- Publication type:
- Article